Torrent Pharma Inc. is recalling 27,312 bottles of Telmisartan and Hydrochlorothiazide (40 mg/12.5 mg) tablets, a prescription medication used to treat high blood pressure. The recall was initiated because the product may be superpotent, meaning it contains higher levels of the active ingredient hydrochlorothiazide than specified. No injuries or incidents related to this issue have been reported to date.
Taking superpotent blood pressure medication can cause an excessive drop in blood pressure or electrolyte imbalances. This poses a health risk, particularly to patients who may be more sensitive to changes in their blood pressure levels.
You have 2 options:
Manufactured by Torrent Pharmaceuticals LTD, India for Torrent Pharma Inc., Basking Ridge, NJ. Total quantity: 27,312 Bottles.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.